Harriet is a leader in our Life Sciences Practice. She serves pharmaceutical and biotechnology clients on strategy and organizational topics across the United States, Asia, and Europe. A scientist by training, Harriet coleads the McKinsey Cancer Center in North America and the R&D organization and operating model group.
Harriet has worked with a broad set of pharmaceutical clients on R&D topics including portfolio strategy, external innovation models, asset acceleration, organizational design and operating models, as well as integration and transformation support. She has also spent a considerable amount of time working at the interface of commercial and development areas, including launch planning and evidence generation strategy.
Harriet has expertise across a broad set of therapeutic areas such as: infectious diseases, respiratory, immunology, neurology, nephrology, and vaccines. She also has a particular interest in oncology—including cell therapy—across discovery, translation, development, and commercialization.
Prior to joining McKinsey, Harriet completed a PhD in neuroscience and molecular biology at the University of Oxford, where she also read for a master’s in chemistry with a focus on organic synthesis. Outside of work, Harriet enjoys endurance sports and global travel.